Early research (Phase 1)Ended earlyNCT01028209
What this trial is testing
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Who this might be right for
Alzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Institute for Neurodegenerative Disorders 12